Shots:
Aplagon has dosed the first patient with APAC (IV) in its P-IIa (HEALING) trial in Finland for peripheral arterial occlusive disease (PAOD), leading to chronic limb-threatening ischemia (CLTI)
Trial will evaluate APAC in ~42 CTLI pts across 4 cohorts to assess safety, efficacy, & effects on thrombo-inflammatory biomarkers. Additionally, an associated PET imaging study with…
When we talk about healing, it's often more than just physical recovery; it encompasses emotional and mental restoration as well. Whether recovering from an injury, surgery, or a psychological stressor, the process can sometimes feel slow and frustrating. However, there are several strategies that can help speed up this process, ensuring a more effective and…

